|Articles|July 12, 2018

Clinerion and the P-HIS Development Group of Korea University Medical Center Collaborate

Clinerion has signed a Memorandum of Understanding with the P-HIS Development Group of Korea University Medical Center to support activities in developing a patient data platform in the Republic of Korea for precision medicine.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

ByAndy Studna, Senior Editor

September 3rd 2026

Why Time Savings Is the Largest Driver of RBQM's Financial Value

ByAbigail Dirks, MS,Sylviane de Viron,Andy Studna, Senior Editor

September 3rd 2026

ACT Brief: Human Readiness as Operational Foundation, Early Phase Capacity Consolidation, and AI-Driven Patient Matching Scale

ByAndy Studna, Senior Editor

September 3rd 2026

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

ByPartha Anbil,Anamika Krishanpal, PhD

September 2nd 2026

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

ByAndy Studna, Senior Editor

September 2nd 2026

Clinerion and the P-HIS Development Group of Korea University Medical Center Collaborate

Related Content

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

Why Time Savings Is the Largest Driver of RBQM's Financial Value

ACT Brief: Human Readiness as Operational Foundation, Early Phase Capacity Consolidation, and AI-Driven Patient Matching Scale

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

Trending on Applied Clinical Trials Online

Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

Introducing The Human Side of Clinical Trials